BIOCHEMICAL MARKERS ASSOCIATED WITH THE STAGES OF PROMOTION AND PROGRESSION DURING HEPATOCARCINOGENESIS IN THE RAT

被引:34
作者
PITOT, HC
DRAGAN, Y
SARGENT, L
XU, YH
机构
关键词
D O I
10.2307/3431187
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Specific biochemical changes occurring during hepatocarcinogenesis have been sought by many investigators. The development of multistage models for hepatocarcinogenesis in the rodent has renewed interest in such marker alterations in preneoplastic as well as neoplastic hepatocytes. Preneoplastic altered hepatic foci (AHF) exhibit specific histomorphologic changes as viewed with tinctorial stains and show a variety of biochemical changes as evidenced by enzyme and immunohistochemistry and by other histochemical markers. During the reversible stage of promotion when AHF are scored by multiple markers, the distribution of markers within these lesions differs with the use of different promoting agents. One interpretation of this finding is that each promoting agent stimulates the replication of a set of initiated cells exhibiting the phenotypic characteristics of a specific programmed phenotype. The same markers score AHF during the stage of progression, but many AHF in this stage are phenotypically heterogeneous, exhibiting in tissue sections a "focus-in-focus" pattern of marker alteration. These latter changes can be correlated with the appearance of karyotypic alterations in preneoplastic hepatocytes. On the other hand, it has been difficult to demonstrate the activation, either mutational or transcriptional, of proto-oncogenes until this stage of progression in rat hepatocarcinogenesis. Thus, a study of biochemical and molecular markers during the stages of hepatocarcinogenesis may lead to a better understanding of potential mechanisms involved in the development of neoplasia through the stages of initiation, promotion, and progression.
引用
收藏
页码:181 / 189
页数:9
相关论文
共 77 条
[1]  
BANNASCH P, 1974, VIRCHOWS ARCH B, V17, P29
[2]   PRENEOPLASTIC LESIONS AS END-POINTS IN CARCINOGENICITY TESTING .1. HEPATIC PRENEOPLASIA [J].
BANNASCH, P .
CARCINOGENESIS, 1986, 7 (05) :689-695
[3]  
BANNASCH P, 1975, CYTOLOGIE HEPATOCARC
[4]  
BEER DG, 1986, CANCER RES, V46, P2435
[5]   REGULATION AND EXPRESSION OF 4 CYTOCHROME-P-450 ISOENZYMES, NADPH-CYTOCHROME-P-450 REDUCTASE, THE GLUTATHIONE TRANSFERASE-B AND TRANSFERASE-C AND MICROSOMAL EPOXIDE HYDROLASE IN PRENEOPLASTIC AND NEOPLASTIC LESIONS IN RAT-LIVER [J].
BUCHMANN, A ;
KUHLMANN, W ;
SCHWARZ, M ;
KUNZ, W ;
WOLF, CR ;
MOLL, E ;
FRIEDBERG, T ;
OESCH, F .
CARCINOGENESIS, 1985, 6 (04) :513-521
[6]   APPLICATION OF QUANTITATIVE STEREOLOGY TO THE EVALUATION OF PHENOTYPICALLY HETEROGENEOUS ENZYME-ALTERED FOCI IN THE RAT-LIVER [J].
CAMPBELL, HA ;
XU, YD ;
HANIGAN, MH ;
PITOT, HC .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1986, 76 (04) :751-767
[7]   ONCOGENE EXPRESSION IN RAT HEPATOMAS AND DURING HEPATOCARCINOGENESIS [J].
COTE, GJ ;
LASTRA, BA ;
COOK, JR ;
HUANG, DP ;
CHIU, JF .
CANCER LETTERS, 1985, 26 (02) :121-127
[8]  
DRAGAN YP, IN PRESS PREV MED
[9]   REGRESSION OF LIVER-CELL ADENOMAS ASSOCIATED WITH ORAL-CONTRACEPTIVES [J].
EDMONDSON, HA ;
REYNOLDS, TB ;
HENDERSON, B ;
BENTON, B .
ANNALS OF INTERNAL MEDICINE, 1977, 86 (02) :180-182
[10]   REACTIVITY OF MONOCLONAL-ANTIBODIES TO ONCOPROTEINS WITH NORMAL RAT-LIVER, CARCINOGEN-INDUCED TUMORS, AND PREMALIGNANT LIVER-LESIONS [J].
EMBLETON, MJ ;
BUTLER, PC .
BRITISH JOURNAL OF CANCER, 1988, 57 (01) :48-53